Group One Trading
LAB icon

Group One Trading’s Standard BioTools LAB Stock Holding History

Group One Trading’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$197 Sell
214
-26,492
-99% -$32.1K ﹤0.01% 7393
2025
Q4 		$34.2K Buy
26,706
+6,221
+30% +$8.36K ﹤0.01% 5911
2025
Q3 		$26.6K Buy
20,485
+1,116
+6% +$1.46K ﹤0.01% 6478
2025
Q2 		$23.2K Sell
19,369
-6,875
-26% -$7.62K ﹤0.01% 6162
2025
Q1 		$28.3K Buy
26,244
+15,769
+151% +$22.1K ﹤0.01% 5585
2024
Q4 		$18.3K Buy
+10,475
New +$19.5K ﹤0.01% 5754
2023
Q4 		– Sell
-9,506
Closed -$20.3K – 7803
2023
Q3 		$27.6K Sell
9,506
-214
-2% -$560 ﹤0.01% 5623
2023
Q2 		$18.8K Buy
+9,720
New +$19.2K ﹤0.01% 6029
2023
Q1 		– Sell
-45,084
Closed -$89.1K – 7585
2022
Q4 		$52.7K Buy
45,084
+12,127
+37% +$14.9K ﹤0.01% 4952
2022
Q3 		$36K Sell
32,957
-56,702
-63% -$85.7K ﹤0.01% 5658
2022
Q2 		$143K Buy
89,659
+15,915
+22% +$39.4K ﹤0.01% 4637
2022
Q1 		$265K Buy
73,744
+33,585
+84% +$116K ﹤0.01% 4505
2021
Q4 		$157K Sell
40,159
-5,739
-13% -$26.9K ﹤0.01% 5325
2021
Q3 		$302K Sell
45,898
-25,084
-35% -$165K ﹤0.01% 4742
2021
Q2 		$437K Buy
70,982
+19,666
+38% +$105K ﹤0.01% 4359
2021
Q1 		$232K Buy
+51,316
New +$282K ﹤0.01% 4875
2020
Q4 		– Sell
-134,214
Closed -$882K – 6755
2020
Q3 		$997K Buy
134,214
+134,054
+83,784% +$925K ﹤0.01% 2200
2020
Q2 		$1K Sell
160
-30,153
-99% -$105K ﹤0.01% 5644
2020
Q1 		$77K Sell
30,313
-4,924
-14% -$16.2K ﹤0.01% 3470
2019
Q4 		$123K Sell
35,237
-3,200
-8% -$11.3K ﹤0.01% 3508
2019
Q3 		$178K Buy
+38,437
New +$303K ﹤0.01% 3164
2017
Q4 		– Sell
-23,155
Closed -$117K – 5025
2017
Q3 		$117K Buy
23,155
+17,855
+337% +$75.1K ﹤0.01% 3133
2017
Q2 		$21K Buy
+5,300
New +$25.1K ﹤0.01% 3932
2016
Q2 		– Sell
-4,936
Closed -$46.4K – 4781
2016
Q1 		$40K Buy
+4,936
New +$35.6K ﹤0.01% 3383
2015
Q4 		– Sell
-2,531
Closed -$24.9K – 4911
2015
Q3 		$21K Buy
2,531
+2,479
+4,767% +$39K ﹤0.01% 4010
2015
Q2 		$1K Sell
52
-973
-95% -$30.7K ﹤0.01% 4748
2015
Q1 		$43K Buy
+1,025
New +$40.5K ﹤0.01% 3447
2014
Q3 		– Sell
-2,162
Closed -$60.8K – 5308
2014
Q2 		$64K Sell
2,162
-15,297
-88% -$490K ﹤0.01% 3368
2014
Q1 		$769K Sell
17,459
-19,881
-53% -$875K 0.01% 1290
2013
Q4 		$1.43M Buy
37,340
+37,334
+622,233% +$1.1M 0.02% 863
2013
Q3 		$0 Buy
+6
New +$118 ﹤0.01% 5413

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Group One Trading's LAB Position: Q1 2026 in Review

Group One Trading reduced its Standard BioTools (LAB) stake by 99% in Q1 2026, selling an estimated $32.1K and leaving 214 shares worth $197. The position accounts for ﹤0.01% of the portfolio, ranked #7393.

Group One Trading first reported a position in LAB in Q3 2013 and has held it in 31 quarters since. The position peaked at $1.43M in Q4 2013. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Group One Trading held 214 shares of Standard BioTools worth $197 as of Q1 2026.
  • Group One Trading sold 26,492 Standard BioTools shares in Q1 2026, an estimated $32.1K.
  • Standard BioTools made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7393 holding.
  • Group One Trading first reported a position in Standard BioTools in Q3 2013 and has held it in 31 quarters since.
  • Group One Trading's Standard BioTools position peaked at $1.43M in Q4 2013.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.